Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
levothyroxine integrin alpha-v small molecule NA drugbank Disease Management[MeSHID:D019468]
Hypothyroidism[MeSHID:D007037]
Thyroid Gland[MeSHID:D013961]
Pituitary Gland[MeSHID:D010902]
Operative Surgical Procedures[MeSHID:D013514]
Thyroid carcinoma[MeSHID:D013964]
Neoplasm Metastasis[MeSHID:D009362]
Hypothalamic structure[MeSHID:D007031]
Cell Differentiation process[MeSHID:D002454]
Pituitary Diseases[MeSHID:D010900]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved unknown
levothyroxine integrin beta-3 small molecule NA drugbank Disease Management[MeSHID:D019468]
Hypothyroidism[MeSHID:D007037]
Thyroid Gland[MeSHID:D013961]
Pituitary Gland[MeSHID:D010902]
Operative Surgical Procedures[MeSHID:D013514]
Thyroid carcinoma[MeSHID:D013964]
Neoplasm Metastasis[MeSHID:D009362]
Hypothalamic structure[MeSHID:D007031]
Cell Differentiation process[MeSHID:D002454]
Pituitary Diseases[MeSHID:D010900]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved unknown
levothyroxine thyroid hormone receptor alpha small molecule Successful target TTD , drugbank , DGIDB Disease Management[MeSHID:D019468]
Hypothyroidism[MeSHID:D007037]
Thyroid Gland[MeSHID:D013961]
Pituitary Gland[MeSHID:D010902]
Operative Surgical Procedures[MeSHID:D013514]
Thyroid carcinoma[MeSHID:D013964]
Neoplasm Metastasis[MeSHID:D009362]
Hypothalamic structure[MeSHID:D007031]
Cell Differentiation process[MeSHID:D002454]
Pituitary Diseases[MeSHID:D010900]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 6.37 approved agonist
levothyroxine thyroid hormone receptor beta small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Hypothyroidism[MeSHID:D007037]
Thyroid Gland[MeSHID:D013961]
Pituitary Gland[MeSHID:D010902]
Operative Surgical Procedures[MeSHID:D013514]
Thyroid carcinoma[MeSHID:D013964]
Neoplasm Metastasis[MeSHID:D009362]
Hypothalamic structure[MeSHID:D007031]
Cell Differentiation process[MeSHID:D002454]
Pituitary Diseases[MeSHID:D010900]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.58 approved agonist
click here to return to the previous page